906 related articles for article (PubMed ID: 11776297)
1. Blockade of CD40/CD40 ligand interactions prevents induction of factor VIII inhibitors in hemophilic mice but does not induce lasting immune tolerance.
Reipert BM; Sasgary M; Ahmad RU; Auer W; Turecek PL; Schwarz HP
Thromb Haemost; 2001 Dec; 86(6):1345-52. PubMed ID: 11776297
[TBL] [Abstract][Full Text] [Related]
2. Long-term persistence of anti-factor VIII antibody-secreting cells in hemophilic mice after treatment with human factor VIII.
Hausl C; Maier E; Schwarz HP; Ahmad RU; Turecek PL; Dorner F; Reipert BM
Thromb Haemost; 2002 May; 87(5):840-5. PubMed ID: 12038787
[TBL] [Abstract][Full Text] [Related]
3. Blockade of CD40-CD40 ligand pathway induces tolerance in murine contact hypersensitivity.
Tang A; Judge TA; Turka LA
Eur J Immunol; 1997 Dec; 27(12):3143-50. PubMed ID: 9464799
[TBL] [Abstract][Full Text] [Related]
4. Single cell analysis of factor VIII-specific T cells in hemophilic mice after treatment with human factor VIII.
Sasgary M; Ahmad RU; Schwarz HP; Turecek PL; Reipert BM
Thromb Haemost; 2002 Feb; 87(2):266-72. PubMed ID: 11858486
[TBL] [Abstract][Full Text] [Related]
5. Modulation of factor VIII-specific memory B cells.
Reipert BM; Allacher P; Hausl C; Pordes AG; Ahmad RU; Lang I; Ilas J; Windyga J; Klukowska A; Muchitsch EM; Schwarz HP
Haemophilia; 2010 May; 16(102):25-34. PubMed ID: 20536983
[TBL] [Abstract][Full Text] [Related]
6. Mucosally induced systemic T cell unresponsiveness to ovalbumin requires CD40 ligand-CD40 interactions.
Kweon MN; Fujihashi K; Wakatsuki Y; Koga T; Yamamoto M; McGhee JR; Kiyono H
J Immunol; 1999 Feb; 162(4):1904-9. PubMed ID: 9973457
[TBL] [Abstract][Full Text] [Related]
7. Co-stimulation blockade, hemophilic inhibitors and tolerance.
Qian J; Saenko E; Scott D
Thromb Haemost; 2001 Dec; 86(6):1343-4. PubMed ID: 11776296
[No Abstract] [Full Text] [Related]
8. The role of CD40-CD40 ligand interactions in suppression of human B cell responsiveness by CD4+ T cells.
Hirohata S
Cell Immunol; 1997 Nov; 182(1):20-8. PubMed ID: 9427806
[TBL] [Abstract][Full Text] [Related]
9. Mechanism of the immune response to human factor VIII in murine hemophilia A.
Wu H; Reding M; Qian J; Okita DK; Parker E; Lollar P; Hoyer LW; Conti-Fine BM
Thromb Haemost; 2001 Jan; 85(1):125-33. PubMed ID: 11204564
[TBL] [Abstract][Full Text] [Related]
10. Cytokine production by CD4+ T cells specific for coagulation factor VIII in healthy subjects and haemophilia A patients.
Hu G; Guo D; Key NS; Conti-Fine BM
Thromb Haemost; 2007 May; 97(5):788-94. PubMed ID: 17479189
[TBL] [Abstract][Full Text] [Related]
11. Novel therapies for immune tolerance in haemophilia A.
Collins PW
Haemophilia; 2006 Dec; 12 Suppl 6():94-100; discussion 100-1. PubMed ID: 17123401
[TBL] [Abstract][Full Text] [Related]
12. Long-term induction of immune tolerance after blockade of CD40-CD40L interaction in a mouse model of hemophilia A.
Rossi G; Sarkar J; Scandella D
Blood; 2001 May; 97(9):2750-7. PubMed ID: 11313267
[TBL] [Abstract][Full Text] [Related]
13. Role of CD154 in the secondary immune response: the reduction of pre-existing splenic germinal centers and anti-factor VIII inhibitor titer.
Qian J; Burkly LC; Smith EP; Ferrant JL; Hoyer LW; Scott DW; Haudenschild CC
Eur J Immunol; 2000 Sep; 30(9):2548-54. PubMed ID: 11009088
[TBL] [Abstract][Full Text] [Related]
14. Induction of human factor VIII inhibitors in rats by immunization with human recombinant factor VIII: a small animal model for humans with high responder inhibitor phenotype.
Jarvis MA; Levin LG; Harrison JA; DePianto DJ; Suzuki CM; Ziaja CL; Brown JE; Jolly KW; Reisner HM; Abildgaard CF; Powell JS
Thromb Haemost; 1996 Feb; 75(2):318-25. PubMed ID: 8815584
[TBL] [Abstract][Full Text] [Related]
15. CD40 ligand-CD40 interactions are necessary for the initiation of insulitis and diabetes in nonobese diabetic mice.
Balasa B; Krahl T; Patstone G; Lee J; Tisch R; McDevitt HO; Sarvetnick N
J Immunol; 1997 Nov; 159(9):4620-7. PubMed ID: 9379064
[TBL] [Abstract][Full Text] [Related]
16. CD40L is necessary for the priming of effector cells for lymphocytic and granulomatous experimental autoimmune thyroiditis.
Peterson KE; Braley-Mullen H
J Autoimmun; 1999 Feb; 12(1):1-12. PubMed ID: 10028017
[TBL] [Abstract][Full Text] [Related]
17. Inhibition of CD40 ligand (CD154) in the treatment of factor VIII inhibitors.
Ewenstein BM; Hoots WK; Lusher JM; DiMichele D; White GC; Adelman B; Nadeau K
Haematologica; 2000 Oct; 85(10 Suppl):35-9. PubMed ID: 11187868
[TBL] [Abstract][Full Text] [Related]
18. Immunoglobulin isotypes and functional anti-FVIII antibodies in response to FVIII treatment in Balb/c and C57BL/6 haemophilia A mice.
Qadura M; Waters B; Burnett E; Chegeni R; Hough C; Othman M; Lillicrap D
Haemophilia; 2011 Mar; 17(2):288-95. PubMed ID: 21091850
[TBL] [Abstract][Full Text] [Related]
19. Blockade of CD40/CD40 ligand interactions attenuates skin fibrosis and autoimmunity in the tight-skin mouse.
Komura K; Fujimoto M; Yanaba K; Matsushita T; Matsushita Y; Horikawa M; Ogawa F; Shimizu K; Hasegawa M; Takehara K; Sato S
Ann Rheum Dis; 2008 Jun; 67(6):867-72. PubMed ID: 17823201
[TBL] [Abstract][Full Text] [Related]
20. CD40-mediated stimulation contributes to lymphocyte proliferation, antibody production, eosinophilia, and mastocytosis during an in vivo type 2 response, but is not required for T cell IL-4 production.
Lu P; Urban JF; Zhou XD; Chen SJ; Madden K; Moorman M; Nguyen H; Morris SC; Finkelman FD; Gause WC
J Immunol; 1996 May; 156(9):3327-33. PubMed ID: 8617957
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
